Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®
Condition: Lung Cancer; Neoplasms, Lung; Neoplasms, Pulmonary; Pulmonary Cancer; Pulmonary Neoplasms; Cancer of Lung
MeSH terms: Lung Neoplasms; Neoplasms
Study type: Interventional

Summary: 
      The purpose of this study is to demonstrate how Moovcare®, a mobile medical application, can
      be used to monitor Patient-Reported Outcomes (PROs) related to cancer treatment, cancer
      complications, and cancer relapse in patients with lung cancer. PROs are symptoms directly
      reported by patients through the completion of a survey. Up to 50 patients undergoing
      treatment and/or surveillance for new or existing diagnoses of lung cancer at the University
      of North Carolina's Lineberger Comprehensive Cancer Center will be prospectively enrolled to
      the use of the mobile medical application Moovcare® for 6 months. Moovcare® is not FDA
      approved, and its role in improving clinical care is being studied through this research.
      Moovcare® automatically delivers electronic patient reported outcome (ePRO) surveys on common
      symptoms experienced by lung cancer patients.
    

Detailed description: 
      This is a single site nonrandomized feasibility study of approximately 50 participants on
      treatment and/or surveillance for new or existing diagnoses of lung cancer who will be
      assigned to a single-arm involving monitoring of their patient-reported outcomes using a
      mobile medical application. The study procedures include monitoring of patient symptoms using
      automated weekly PRO surveys delivered by Moovcare® and assessment of outcomes including
      quality of life at baseline and at monthly intervals, as well as patient satisfaction at 6
      months. The clinical care team will receive an alert if the PRO survey suggests increased or
      worsening symptoms. The care team will follow their usual protocols for the management of
      symptoms. The patient clinical information will also be abstracted from the medical record to
      assess clinical outcomes. The provider's satisfaction survey will be assessed via surveys.
    

Intervention name(s): Moovcare® use
Intervention type(s): Device
Intervention description(s): Moovcare® performs symptom monitoring by automatically delivering ePRO surveys on common symptoms experienced by lung cancer patients. Results are stored in a secure web-based portal for provider review. Providers will manage ePRO responses through a combination of reports graphically displaying responses over time and e-mail alerts about concerning levels or combinations of symptoms.
Intervention model: Single Group Assignment
Intervention model description: This is a single site nonrandomized feasibility study, participants on treatment and/or surveillance for new or existing diagnoses of lung cancer were assigned to a single arm involving monitoring of their patient-reported outcomes using a mobile medical application. The study population will include patients with a diagnosis of lung cancer undergoing outpatient treatment or surveillance at UNC. Patients will be recruited from the Multidisciplinary Thoracic Oncology Program (MTOP) clinics at the University of North Carolina over 10-12 months and undergo ePRO monitoring for 6 months or until criteria for coming off study are met, whichever comes first.
Masking: None (Open Label)
Primary purpose: Health Services Research
Keywords: Patient Reported Outcome; Feasibility; Acceptability; Moovcare®